Cera Sanitaryware share price today

Cera Sanitaryware Ltd's share price was ₹4,777.30 at the close on 4 November 2026. It has been falling for 4 weeks. That is 14.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹4,406 and ₹6,460, and at that close it sat 18% of the way up from that low.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Cera Sanitaryware Ltd is in stage 4. The phase helps read everything below.

Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 13 weeks running.

Over the last 11 years the share price moved +171% while the NIFTY 500 moved +251%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 7 August 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Two changes stood out: profit down on a year earlier for 4 quarters in a row and operating margin down 3 points on a year earlier.

1. Profit down on a year earlier for 4 quarters in a row

   In the June 2026 quarter profit was ₹45 crore, -4.3% on a year earlier.

   Why: The latest profit fall came because a worker pay settlement cost money, running only one kiln cut output, old project orders were closed at old prices, and price rises had not yet reached customers.

   Next results: check if profit recovers as project price rises start to show and brass and gas costs stay steady.

   From the earnings call on 8 Aug 2026.

2. Operating margin down 3 points on a year earlier

   10% in the June 2026 quarter, from 13%.

   Why: Margin fell because worker settlement costs, running one kiln, closing old price project orders, and delayed price rises all hit in the quarter.

   Next results: check if margins recover as retail and project price rises flow through and brass and gas costs stay steady.

   From the earnings call on 8 Aug 2026.

For April to June 2026 (the quarter ended 30 June 2026), Cera Sanitaryware reported revenue of ₹486 crore, up 19.4% from ₹407 crore a year earlier, and a profit of ₹45.0 crore, down 4.3% from ₹47.0 crore.

Cera Sanitaryware results: April to June 2026 against a year earlier

The next results, for July to September 2026, are due by 14 November 2026: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Cera Sanitaryware's management discussed these results on a call held on 8 August 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 June 2026). Revenue and profit in ₹ crore.

Cera Sanitaryware closed at ₹4,777.30 on 4 November 2026, down 20.3% from ₹5,997.00 a year earlier (7 November 2025) and down 13.4% over five years. Its highest weekly close since March 2016 was ₹10,420.45 on 9 August 2024.

Cera Sanitaryware share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

560 weekly closes from 11 March 2016 to 4 November 2026.

4 Nov 2026: Cera Sanitaryware closed at ₹4,777.30, up 8.4% on the week and down 6.3% on the month. 8 Aug 2026: Cera Sanitaryware held its results call for April to June 2026. Management guided: FY27 revenue growth 18% to 20%.

Earlier

• 7 Jul 2026: ex-date for a dividend of ₹75 a share.
• Results for April to June 2026: Revenue up 19.4% and profit down 4.3% on a year earlier.
• Our read, 27 Jun 2026: The business itself is intact: EPS compounded at a 17% annual rate from FY21 to FY25, faucetware is constrained at 106% utilization, and January to March 2026 showed the first clear margin recovery to 15.2%.

Our read of the business

The business itself is intact: EPS compounded at a 17% annual rate from FY21 to FY25, faucetware is constrained at 106% utilization, and January to March 2026 showed the first clear margin recovery to 15.2%.

January to March 2026: Margin recovery landed, 15.2% operating profit from Q3 trough of 10.2%; faucetware +24.3% at 106% utilization.

Our read after the January to March 2026 results, written 27 June 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.

Cera Sanitaryware paid ₹75 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 1.57% at the ₹4,777.30 close on 4 November 2026. The last was a dividend of ₹75 a share, ex-date 7 July 2026.

Cera Sanitaryware dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Yes. Cera Sanitaryware Ltd paid out 47% of its profit as dividends in FY26, and it paid a dividend in each of its last 12 reported years.

From the NSE corporate-actions record, read 5 November 2026.

On the call for April to June 2026, held on 8 August 2026, Cera Sanitaryware's management guided: FY27 revenue growth 18% to 20%.

“For the whole year, we are confident that we will deliver the margins we discussed earlier, of 13.5% to 14%.”Vikas Kothari, on the call for April to June 2026

What management guided

• FY27 operating margin 13.5% to 14%, with absolute operating profit adjusted for lower turnover presentation.
• Retail price increases to flow through from July and project pricing after Q2.
• FY27 staff costs around ₹300 crore, including total wage-settlement P&L impact of ₹18.3 crore.
• FY27 capital spending ₹43 crore and brand-building budget ₹85 crore; A&P can rise if required.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for April to June 2026, 8 August 2026.

What is changing at Cera Sanitaryware, from the latest results and calls: faucetware demand ramp and capacity relief, margin recovery via price hikes and discount normalisation and morbi disruption creates organised-player share-capture window.

• Faucetware demand ramp and capacity relief. Faucetware at 106% utilization with ₹4-5 crore debottlenecking expanding capacity by 16% to 5 lakh pieces per month by January to March 2027. ✓ fact
• Margin recovery via price hikes and discount normalisation. Cumulative 12% sanitaryware and 16% faucetware price hikes implemented March-April, recovering most of a 30% brass cost increase; January to March 2026 margins recovered to 15.2% from Q3's 10.2%. ✓ fact
• Morbi disruption creates organised-player share-capture window. Gas supply shocks disabled Morbi-based unorganised manufacturers for 2-3 quarters; Cera's GAIL-backed supply and finished-goods inventory buffer enabled market share capture. ✓ fact
• Senator and PolyPlus brand scale-up. Senator and PolyPlus aiming for ₹70-80 crore combined FY27 revenue (vs ₹19 crore FY26), with Senator break-even in FY28. ✓ fact

We check 16 kinds of change in every company, such as costs spread over more sales, higher-value products, new orders, new regions or falling debt, against its reported numbers and what management said on its calls. Only changes the numbers back are shown.

Our read after the January to March 2026 results, written 27 June 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.

If operating margin in Q1 or July to September 2026 falls back below 13% despite the full-quarter benefit of the March-April price hikes, that invalidates the recovery thesis and suggests pricing power is insufficient against structural competitive discount pressure.

Each change stops working if

• Faucetware demand ramp and capacity relief: Brass prices surge further beyond the 29-30% already absorbed, requiring another pricing round that triggers dealer pushback and volume deceleration before the January to March 2027 capacity expansion lands.
• Margin recovery via price hikes and discount normalisation: Retail demand cools in Q1-July to September 2026 (post-monsoon seasonality), forcing dealers back to high-discount tactics to clear channel inventory before the project pricing cascade fully takes effect.
• Morbi disruption creates organised-player share-capture window: Morbi capacity fully restores and gas prices normalise by July to September 2026, ending the supply advantage and reversing any volume gained from disrupted competitors.
• Senator and PolyPlus brand scale-up: Senator revenue tracks below ₹40 crore in FY27 (below the current FY27 guidance of ₹40-45 crore), which would be the third consecutive major downgrade and would signal the premium brand model has structural distribution or positioning problems.

The main risks

• Management execution gap on new brands: Four guidance misses in three concalls on Senator/PolyPlus revenue, margin goals, store rollout and dealer network, a pattern that caps management credibility for FY27 delivery. ⚠ estimate
• Morbi outsourcing dependency and tile segment vulnerability: 60% of sanitaryware and 46% of faucetware sourced from Morbi; tiles fully outsourced, near-term advantage from disruptions could reverse if Morbi recovers faster than expected. ⚠ estimate

Our read after the January to March 2026 results, written 27 June 2026. The April to June 2026 results are out since, so this part may be out of date until we update it.

When Cera Sanitaryware reports July to September 2026, these are the 4 checks that show whether the story is still on course. First: Q2 profitability: check whether residual old-project pricing drag eases as revised contracts begin contributing.

Cera Sanitaryware is on 2 of our India lists: 52 week high & low and Dividend stocks.

Cera Sanitaryware Ltd earned ₹45.0 Cr of net profit in the Jun 2026 quarter, −4.3% on the same quarter a year earlier. Full-year FY26 profit was ₹204 Cr. Over 10 years profit has grown 9.4% a year on average. That is 9.3% of the quarter's revenue. The same quarter a year earlier earned ₹47.0 Cr.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

For the full year, FY26 profit was ₹204 Cr (−17.1% on the year before).

Why profit moved: revenue changed +19.4% on a year earlier and the margin moved −3.0 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −19.7% and revenue +9.5%. Profit is growing slower than sales: rising costs are taking part of the growth.

FY26-Q4. revenue ₹624 Cr and profit ₹77 Cr as reported.

FY27-Q1. revenue ₹486 Cr and profit ₹45 Cr as reported.

Why-sources: our stock research file (27 June 2026) and the company’s own results for those quarters.

Cera Sanitaryware Ltd reported ₹486 Cr of revenue in the Jun 2026 quarter, +19.4% on the same quarter a year earlier. That is the 3rd quarter in a row with growth on the year before. Over 10 years it has grown 8.4% a year on average. The last full year, FY26, came in at ₹2,050 Cr.

Revenue is everything the company billed its customers in the period.

Why this happened. Geopolitical disruptions from February 2026 cut gas supply to Morbi cluster, severely constraining unorganised sanitaryware manufacturers who lack long-term gas supply arrangements. Cera, sourcing 64% of gas from GAIL at a subsidised Rs 35.55 per cubic metre (C027), maintained production continuity. The Rs 303 crore finished-goods inventory accumulated by March (C019) provided 2-3 months of customer supply runway while Morbi operations gradually reopened. Management characterised this as an opportunity for integrated manufacturers, the 60% of sanitaryware currently outsourced to Morbi (C028) is a medium-term vulnerability, but in the disruption window it created a demand-pull advantage for…

The last four reported quarters add to ₹2,097 Cr.

FY26 revenue was ₹2,050 Cr, +7.0% on the year before.

Recent pace: the last four quarters grew +9.5% on average, against 8.4% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +9.0%, against +6.7% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −17.8%, against −6.1% a year (rolling over).

FY26-Q4. revenue ₹624 Cr and profit ₹77 Cr as reported.

FY27-Q1. revenue ₹486 Cr and profit ₹45 Cr as reported.

Why-sources: our stock research file (27 June 2026) and the company’s own results for those quarters.

Cera Sanitaryware Ltd's operating margin was 10.0% in the Jun 2026 quarter, 3.0 percentage points lower than the same quarter a year ago. Across 12 years it has been between 12.0% and 17.0%. The latest quarter is below every full year in that period.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why this happened. Q4 FY26 EBITDA at 15.2% (C005) versus Q3's 10.2% (C006) represents a 500-basis-point sequential recovery in one quarter, driven by the March-April price hike flow-through to retail and initial inventory drawdown. The remaining recovery lever is trade discount normalisation, management described this as a gradual journey dependent on sustained demand, and the project pricing cascade, where March price hikes reach project customers only after a 5-6 month lag beginning Q2 FY27. If both levers execute, FY27 EBITDA guidance of 14-15% (C008) is achievable with operating leverage on 18-20% revenue growth (C007).

Why the margin moved: operating margin changed −2.9 percentage points on the year while gross margin changed −5.5 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

FY26-Q4. revenue ₹624 Cr and profit ₹77 Cr as reported.

FY27-Q1. revenue ₹486 Cr and profit ₹45 Cr as reported.

Why-sources: our stock research file (27 June 2026) and the company’s own results for those quarters.

Over the last 3 years, 81% of Cera Sanitaryware Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹212 Cr of operating cash against ₹204 Cr of profit. After ₹27.0 Cr of spending on assets, ₹185 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 81% of profit came in as cash: the cash cycle got 33 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Cera Sanitaryware Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 111 days in FY26, up from 78 days in FY21. It spent ₹154 Cr on assets over the last 3 years. Customers take 49 days to pay, and stock sits for 139 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Why this happened. Faucetware contributed 43% of Q4 FY26 revenue and grew 24.3% year-on-year, making it the highest-growth segment. At 106% utilization (C010), the constraint is supply, not demand. Volume guidance for FY27 is 10-12% growth with 8% price realisation (C007), and the capacity addition removes the binding constraint. This driver has 3 quarters of clear visibility.

At FY26 sales of ₹2,050 Cr, each day of that cycle ties up about ₹5.6 Cr, so roughly ₹623 Cr is tied up in the business at any time.

FY26: customers took 49 days to pay and stock sat for 139 days, about 4.6 months of sales sitting as stock, for a full cycle of 111 days, longer than FY21's 78.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 139 days. Customers pay about 49 days after that. Suppliers are paid at 77 days. Together that makes the 111-day cycle.

Spending on assets: ₹154 Cr over the last 3 years, against ₹112 Cr of depreciation (the yearly wear and tear on existing assets). So it is building a little beyond replacing what wears out. Work still in progress is ₹7.0 Cr (FY26): assets paid for that are not earning yet.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

Cera Sanitaryware Ltd's P/E is 29.8×, near the low end of its own history: it has been lower only 17% of the time. Its usual P/E (the middle reading) is 36.7×, over 10 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Jun 2026 add up to ₹157.37.